Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Addiction. 2019 Aug 4;115(2):239–246. doi: 10.1111/add.14735

Figure 1.

Figure 1.

Weekly treatment attendance and opioid UDT results across a 24-week placebo-controlled trial of XR-NTX for opioid dependence. Each row represents an individual patient’s 24-week course. Blue dots indicate weeks when the patient attended treatment and the UDT result was negative for opioids. Green triangles indicate weeks when the patient attended treatment and the UDT result was positive for opioids. Blanks indicate weeks with a missing UDT. UDT = urine drug test; XR-NTX = extended-release injection naltrexone.